1159. Pharmacokinetics, Safety, and Tolerability of Imipenem/Cilastatin/Relebactam in Pediatric Participants With Confirmed or Suspected Gram-negative Bacterial Infections: A Phase...

por Bradley, John S, Makieieva, Nataliia, Tøndel, Camilla, Roilides, Emmanuel, Kelly, Matthew S, Patel, Munjal, Vaddady, Pavan, Maniar, Alok, Zhang, Ying, Paschke, Amanda, Butterton, Joan R, Chen, Luke F
Publicado 2021

1230. Clinical and Microbiologic Outcomes by Causative Pathogen in Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (HABP/VABP) Treated with Imipenem/Cilastatin (IMI)...

por Losada, Maria C, Maniar, Alok, Du, Jiejun, Brown, Michelle L, Young, Katherine, Hilbert, David W, Tipping, Robert, DeRyke, C Andrew, Butterton, Joan R, Paschke, Amanda, Chen, Luke F
Publicado 2020